PROS1 and COVID-19: In this study, we generated SARS-CoV-2-specific CAR-T cells and stimulated them with S proteins, which mimics the signatures of T-cell responses seen in COVID-19 patients, including distinct memory, exhausted, and regulatory T-cell phenotypes [22].